SCHEMBL69479

SCHEMBL69479

CC(C)(C)c1cc(Cl)c(O)c(Cc2cc(C(C)(C)C)cc(Cl)c2O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 9/20 0.48
HSP90AA1 P07900 2/20 0.44
HSPA5 P11021 3/20 0.44
CYP2C9 P11712 7/20 0.43
HIF1A Q16665 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
CYP2D6 P10635 5/20 0.42
CYP1A2 P05177 4/20 0.42
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
TP53 P04637 2/20 0.41
ACLY P53396 1/20 0.41
HSD17B10 Q99714 3/20 0.39
CYP3A4 P08684 3/20 0.39
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
MAPK1 P28482 3/20 0.38
MEN1 O00255 2/20 0.38
USP2 O75604 2/20 0.38
ESR1 P03372 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30250573 1.00 CYP2C19 (0.48) CYP2C19HSP90AA1HSPA5CYP2C9HIF1A
SCHEMBL11773434 0.86 CYP2C19 (0.47) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP2D6
SCHEMBL14702177 0.85 CYP2C19 (0.46) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP2D6
SCHEMBL11443946 0.85 CYP2C19 (0.46) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP2D6
Hydrochloric Acid SCHEMBL11492917 0.83 CYP2C19 (0.44) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP2D6
SCHEMBL6321695 0.83 GABRA1 (0.52) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP1A2
SCHEMBL10947681 0.82 CYP3A4 (0.54) CYP2C19HSP90AA1HSPA5CYP2C9HIF1A
SCHEMBL29065613 0.81 GABRA1 (0.50) CYP2C19CYP2C9HIF1ASMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL11242368 0.80 CYP2C19 (0.42) CYP2C19CYP2C9HIF1ACYP2D6CYP1A2
SCHEMBL70807 0.79 CYP2C19 (0.53) CYP2C19HSPA5CYP2C9HIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149323-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS ORPHA BIOTECH S.R.L. (IT) 2023-05-18 US claimed
EP-4125833-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS Orpha Biotech S.r.l. (IT) 2023-02-08 EP claimed
WO-2021198844-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS ORPHA BIOTECH S.R.L. (IT) 2021-10-07 WO claimed
US-20230149323-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS ORPHA BIOTECH S.R.L. (IT) 2023-05-18 US disclosed
EP-4125833-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS Orpha Biotech S.r.l. (IT) 2023-02-08 EP disclosed
WO-2021198844-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS ORPHA BIOTECH S.R.L. (IT) 2021-10-07 WO disclosed
EP-2479203-A1 AROMATIC POLYESTER Muroran Institute of Technology (JP) 2012-07-25 EP disclosed
US-20120172570-A1 AROMATIC POLYESTER NITTA CORPORATION 2012-07-05 US disclosed
US-8129493-B2 Aromatic polyester MURORAN INSTITUTE OF TECHNOLOGY (JP) 2012-03-06 US disclosed
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME MURORAN INSTITUTE OF TECHNOLOGY (JP) 2011-09-15 US disclosed
US-20110092662-A1 AROMATIC POLYESTER NITTA CORPORATION (JP) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME F12, PHAX, WDR82 CYP2C19 3009/4885HSP90AA1 106/4885HSPA5 133/4885
US-20230149323-A1 INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS FPR3, FPR1, PLAUR CYP2C19 3289/4885HSP90AA1 2925/4885HSPA5 3074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.